美国婴幼儿益生菌市场规模、份额、竞争格局、按年龄层、产品类型和分销管道的趋势分析报告：2023年至2032年全球市场机会分析和行业预测

2022年美国婴幼儿益生菌市场价值为1.5924亿美元，预计2032年将达到3.7089亿美元，2023年至2032年复合年增长率为9.1%，创历史新高。

婴儿益生菌是含有有益细菌菌株的专门补充品，通常适合 0 至 12 个月大的婴儿。这些製剂旨在支持消化器官系统健康、增强免疫系统并缓解绞痛和尿布疹等问题。它们通常含有婴儿双叉桿菌和鼠李糖乳桿菌等菌株，这些菌株对婴儿敏感的肠道菌丛友好且有益。儿童益生菌适合 1 岁及以上儿童，并提供类似的益处，但使用适合年龄较大儿童需求的菌株，促进整体健康并帮助消化。这两种类型的益生菌都有多种形式，包括滴剂、粉末和锭剂，方便父母服用。美国婴儿消化器官系统疾病的发生率迅速增加，是该族群对益生菌需求的主要驱动力。绞痛、便秘、腹泻和大肠激躁症(IBS) 等消化器官系统问题在幼儿中越来越常见，影响着他们的整体健康和生活品质。由于传统治疗方法可能会给婴儿带来风险和不良副作用，益生菌提供了安全、天然的替代方案。益生菌含有有益细菌，有助于恢復肠道菌丛平衡，强化消化器官系统，缓解各种消化系统疾病的症状。人们越来越认识到益生菌在管理消化器官系统问题方面的潜在益处，这推动了美国市场对婴儿和儿童益生菌的需求。此外，医疗保健专业人士也越来越多地推荐益生菌作为管理婴儿和儿童消化器官系统健康的整体方法的一部分，这将进一步促进未来几年的市场成长。可用的益生菌菌株数量众多，而且不同产品的配方和剂量各不相同，使得消费者和医疗保健提供者很难确定哪些产品最适合和有效地满足他们面临的特定健康需求。此外，缺乏婴儿和儿童使用益生菌的标准化指南使问题更加复杂。如果没有医疗专业人士的明确建议，父母可能不愿意将益生菌纳入孩子的日常保健中，因为担心潜在的副作用或无效的结果。缺乏指导限制了市场的采用，并阻止益生菌充分发挥其解决儿科消化器官系统健康问题的潜力。为了克服这一抑制因素并增强消费者和医疗保健提供者对美国婴儿和儿童益生菌市场的信心，需要製定关于益生菌菌株、配方、剂量和建议剂量的明确指南，包括制定标准。随着益生菌产品在家长中越来越受欢迎和需求不断增长，利用多元化的分销管道覆盖更广泛的消费者群体非常重要。除了传统的实体店外，线上平台还为父母为孩子购买益生菌提供了一种方便快捷的方式，适应忙碌的生活方式并避免地域限制，您可以接触到更广泛的消费者。此外，与医院、小儿科诊所、生育中心等医疗机构合作可以加强益生菌产品的供应。医疗保健提供者在教育家长了解益生菌的好处并为孩子推荐合适的产品方面发挥着重要作用。此外，透过与药局和保健食品商店合作，我们可以提高婴儿和儿童益生菌的认知度和可用性，以便消费者在购买其他保健必需品的同时可以轻鬆找到和购买。製造商和零售商可以利用多元化的分销管道来满足婴幼儿益生菌不断增长的需求，扩大市场覆盖范围并推动美国市场的成长。此外，策略行销工作以及与相关人员的合作可以提高人们对幼儿肠道环境的重要性和益生菌的作用的认识，透过各种分销管道进一步刺激需求，可以促进市场扩张。格柏产品公司和 BioGaiai 等领先公司正在做出重大改变，以产品推出其产品系列，并在美国婴幼儿益生菌市场上站稳脚跟。例如，2020年4月，格柏Goodstart推出了独特的A2婴儿营养系列，以加强产品系列。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

• 市场定义和范围
• 市场动态
  • 促进因素
    • 增加益生菌的创新
    • 千禧世代的父母越来越注重健康
  • 抑制因素
    • 消费者对益生菌产品的功效缺乏认识
    • 益生菌监理不足
  • 机会
    • 益生菌市场在线快速渗透
  • 任务
    • 加工和保质期要求
• 益生菌市场通路动态
• 消费者购买趋势

第四章美国婴幼儿益生菌市场：依形式

• 概述
• 液体
  • 主要市场趋势、成长要素与机会
• 粉末
  • 主要市场趋势、成长要素与机会
• 可咀嚼的
  • 主要市场趋势、成长要素与机会
• 其他的
  • 主要市场趋势、成长要素与机会

第五章美国婴幼儿益生菌市场：依通路划分

• 概述
• 零售药局/药局
  • 主要市场趋势、成长要素与机会
• 百货公司
  • 主要市场趋势、成长要素与机会
• 超级市场/大卖场
  • 主要市场趋势、成长要素与机会
• 电子商务
  • 主要市场趋势、成长要素与机会

第六章美国婴幼儿益生菌市场：依年龄段

• 概述
• 婴儿
  • 主要市场趋势、成长要素与机会
• 孩子
  • 主要市场趋势、成长要素与机会

第七章 竞争格局

• 益生菌销售前10名SKU（2019年）
• 竞争对手的市场占有率分析（2019）
  • i-Health, Inc.
    • i-Health, Inc：公司简介
  • Gerber
    • 格柏：公司简介
  • LoveBug Probiotics
    • LoveBug 益生菌：公司简介
  • Mommy's Bliss Inc.
    • Mommy's Bliss Inc.：公司简介
  • Zarbees, Inc.
    • Zarbees, Inc.：公司简介
  • FIT-BioCeuticals Ltd
    • FIT-BioCeuticals 有限公司：公司简介
  • Florastor
    • Florastor：公司简介
  • BioGaia
    • BioGaia：公司简介
  • Mama's Select
    • 妈妈的选择：公司简介
  • Hyperbiotics
    • Hyperbiotics：公司简介

The U.S. infant and kids probiotics market was valued at $159.24 million in 2022 and is projected to reach $370.89 million by 2032, registering a CAGR of 9.1% from 2023 to 2032.Infant probiotics are specialized supplements containing beneficial bacteria strains suitable for infants, typically aged 0 to 12 months. These formulations aim to support digestive health, strengthen the immune system, and alleviate issues like colic or diaper rash. They often contain strains such as Bifidobacterium infantis or Lactobacillus rhamnosus, which are gentle and beneficial for sensitive infant gut microbiota. Kids' probiotics cater to children above one year old, offering similar benefits but with strains tailored to older children's needs, promoting overall well-being and aiding digestion. Both types of probiotics come in various forms like drops, powders, or chewable tablets, ensuring easy administration for parents.The surge in digestive disorders among infants and children in the United States has become a significant driver propelling the demand for probiotics in this demographic. Digestive issues such as colic, constipation, diarrhea, and irritable bowel syndrome (IBS) are increasingly common among young children, impacting their overall well-being and quality of life. Parents and caregivers are seeking effective solutions to alleviate these discomforts and promote better digestive health for their little ones.As conventional treatments may pose risks or unwanted side effects in infants and young children; probiotics offer a safe and natural alternative. Probiotics contain beneficial bacteria that can help restore the balance of the gut microbiota, strengthen the digestive system, and alleviate symptoms of various digestive disorders. This increased awareness of the potential benefits of probiotics in managing digestive issues has fueled the demand for infant and kids probiotics in the U.S. market. Moreover, healthcare professionals are also more frequently recommending probiotics as part of a holistic approach to managing digestive health in infants and children, further contributing to the market growth in coming years.However, the lack of standardization in the U.S. infant and kids probiotics market poses a significant restraint on market demand. With numerous probiotic strains available and varying formulations and dosages across products, consumers and healthcare providers face challenges in determining which products are most suitable and effective for specific health needs. The lack of consistency leads to confusion and hesitation among consumers, ultimately hindering market growth as parents may opt for alternative remedies or traditional healthcare approaches.Furthermore, the absence of standardized guidelines for probiotic usage in infants and children exacerbates the issue. Without clear recommendations from healthcare professionals, parents may be reluctant to incorporate probiotics into their children's healthcare routine, fearing potential adverse effects or ineffective outcomes. This lack of guidance limits market adoption and prevents probiotics from reaching their full potential in addressing pediatric digestive health issues. Standardization efforts, including the establishment of clear guidelines for probiotic strains, formulations, dosages, and usage recommendations, are crucial to overcoming this restraint and fostering confidence among consumers and healthcare providers in the U.S. infant and kids probiotics market.The expansion of distribution channels presents significant opportunities in the U.S. infant and kids probiotics market. With the increasing popularity and demand for probiotic products among parents, leveraging a diverse range of distribution channels becomes crucial for reaching a wider consumer base. Beyond traditional brick-and-mortar stores, online platforms offer a convenient and accessible avenue for parents to purchase probiotics for their children, catering to busy lifestyles and providing a broader reach to consumers across geographical locations. Moreover, partnerships with healthcare institutions such as hospitals, pediatric clinics, and birthing centers can enhance the availability of probiotic products, as healthcare providers play a crucial role in educating parents about the benefits of probiotics and recommending suitable products for their children.Furthermore, collaboration with pharmacies and health food stores can increase the visibility and accessibility of infant and kids probiotics, allowing consumers to easily find and purchase these products while shopping for other healthcare essentials. By tapping into a diverse array of distribution channels, manufacturers and retailers can capitalize on the growing demand for infant and kids probiotics, expanding market reach, and driving growth in the U.S. market. Moreover, strategic marketing efforts and partnerships with key stakeholders can help raise awareness about the importance of early childhood gut health and the role of probiotics, further fueling demand and driving market expansion through various distribution channels.The major players such as Gerber Products Company, and BioGaiai have adopted product launch as their key developmental strategy to improve their product portfolio and gain a strong foothold in the U.S. infant and kids probiotics market. For instance, in April 2020, Gerber Good Start introduced a unique A2 Infant and Toddler Nutrition range to strengthen its product portfolio in innovative probiotic products.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key benefits for stakeholders
• 1.3. Key market segments
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. Key findings
  • 2.1.1. Top investment pockets
• 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Market dynamics
  • 3.2.1. Drivers
    • 3.2.1.1. Increase in innovations in probiotics
    • 3.2.1.2. Rise in health consciousness among millennial parents
  • 3.2.2. Restraints
    • 3.2.2.1. Lack of awareness among consumers regarding the effectiveness of probiotic products
    • 3.2.2.2. Inadequate regulation of probiotics
  • 3.2.3. Opportunities
    • 3.2.3.1. Surge in online penetration of probiotic market
  • 3.2.4. Challenges
    • 3.2.4.1. Processing and shelf life requirements
• 3.3. Probiotics Market: Channel Dynamics
• 3.4. Consumer buying trends

CHAPTER 4: U.S. INFANT AND KIDS PROBIOTICS MARKET, BY FORM

• 4.1. Overview
• 4.2. Liquid
  • 4.2.1. Key market trends, growth factors, and opportunities
• 4.3. Powder
  • 4.3.1. Key market trends, growth factors, and opportunities
• 4.4. Chewable
  • 4.4.1. Key market trends, growth factors, and opportunities
• 4.5. Other
  • 4.5.1. Key market trends, growth factors, and opportunities

CHAPTER 5: U.S. INFANT AND KIDS PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL

• 5.1. Overview
• 5.2. Retail Pharmacies/Drug Stores
  • 5.2.1. Key market trends, growth factors, and opportunities
• 5.3. Departmental Stores
  • 5.3.1. Key market trends, growth factors, and opportunities
• 5.4. Supermarket/Hypermarket
  • 5.4.1. Key market trends, growth factors, and opportunities
• 5.5. E-commerce
  • 5.5.1. Key market trends, growth factors, and opportunities

CHAPTER 6: U.S. INFANT AND KIDS PROBIOTICS MARKET, BY AGE GROUP

• 6.1. Overview
• 6.2. Baby/Infant
  • 6.2.1. Key market trends, growth factors, and opportunities
• 6.3. Kids
  • 6.3.1. Key market trends, growth factors, and opportunities

CHAPTER 7: COMPETITION LANDSCAPE

• 7.1. Probiotics revenue by top 10 SKU (2019)
• 7.2. Market share analysis by competitor (2019)
  • 7.2.1. i-Health, Inc. (Culturelle)
    • 7.2.1.1. i-Health, Inc. (Culturelle): Company Overview
  • 7.2.2. Gerber
    • 7.2.2.1. Gerber: Company Overview
  • 7.2.3. LoveBug Probiotics
    • 7.2.3.1. LoveBug Probiotics: Company Overview
  • 7.2.4. Mommy's Bliss Inc.
    • 7.2.4.1. Mommy's Bliss Inc. : Company Overview
  • 7.2.5. Zarbees, Inc.
    • 7.2.5.1. Zarbees, Inc. : Company Overview
  • 7.2.6. FIT-BioCeuticals Ltd
    • 7.2.6.1. FIT-BioCeuticals Ltd: Company Overview
  • 7.2.7. Florastor
    • 7.2.7.1. Florastor: Company Overview
  • 7.2.8. BioGaia
    • 7.2.8.1. BioGaia: Company Overview
  • 7.2.9. Mama's Select
    • 7.2.9.1. Mama's Select: Company Overview
  • 7.2.10. Hyperbiotics
    • 7.2.10.1. Hyperbiotics: Company Overview

LIST OF TABLES

• TABLE 01. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY FORM, 2018-2026 ($MILLION)

• TABLE 02. U.S. INFANT AND KIDS PROBIOTICS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017-2026 ($MILLION)

• TABLE 03. U.S. INFANT AND KIDS PROBIOTICS MARKET REVENUE, BY AGE GROUP, 2018-2026 ($MILLION)

LIST OF FIGURES

• FIGURE 01. KEY MARKET SEGMENTS

• FIGURE 02. EXECUTIVE SUMMARY

• FIGURE 03. TOP INVESTMENT POCKETS

• FIGURE 04. MARKET DYNAMIC ANALYSIS

• FIGURE 05. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY FORM, 2018

• FIGURE 06. LIQUID PROBIOTICS MARKET, 2018-2026 ($MILLION)

• FIGURE 07. POWDER PROBIOTICS MARKET, 2018-2026 ($MILLION)

• FIGURE 08. CHEWABLE PROBIOTICS MARKET, 2018-2026 ($MILLION)

• FIGURE 09. OTHER PROBIOTICS MARKET, 2018-2026 ($MILLION)

• FIGURE 10. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2026

• FIGURE 11. RETAIL PHARMACIES/DRUG STORES, 2018-2026 ($MILLION)

• FIGURE 12. DEPARTMENTAL STORES, 2018-2026 ($MILLION)

• FIGURE 13. SUPERMARKET/HYPERMARKET, 2018-2026 ($MILLION)

• FIGURE 14. E-COMMERCE, 2018-2026 ($MILLION)

• FIGURE 15. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY AGE GROUP, 2018-2026

• FIGURE 16. BABY/INFANTS PROBIOTICS MARKET, 2018-2026 ($MILLION)

• FIGURE 17. KIDS PROBIOTICS MARKET, 2018-2026 ($MILLION)